InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.15
(
0.02%
)
Bitcoin
64,360.40
(
0.56%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

fishypete

Send PM Follow Ignore
Followers 0
Posts 337
Boards Moderated 0
Alias Born 03/20/2002

fishypete

Re: None

Monday, 06/10/2002 12:15:09 PM

Monday, June 10, 2002 12:15:09 PM

Post# of 14671
EPA Grants BioShield New Use Approval For Its Antimicrobial To Be Used in



RELATED SYMBOLS: (BSTI)

ATLANTA, Jun 10, 2002 /PRNewswire-FirstCall via COMTEX/ -- BioShield
Technologies, Inc. (OTC Bulletin Board: BSTI); (http://www.bioshield.com/ )
announced today that the EPA has granted Approval for a new use application of
BioShield's Antimicrobial line of products for the Polymers industry. This New
Use Approval significantly extends the use of BioShield's product line as an
anti- static agent as well as to eliminate degradation of the polymer.

This New Use Approval provides BioShield with a quick entry into a new field of
use, which includes, among other things, polymeric coatings, gel coatings, amino
resins, epoxy laminating polymers and blends and copolymers; as outlined in
BioShield's EPA Registration #: 70871-1

About BioShield Technologies, Inc.

BioShield Technologies, Inc. is a Norcross Georgia based emerging growth company
focused in biotechnology and antimicrobial products. Its core business is
committed to the discovery, development, marketing and sale of surface-modifying
antimicrobial and biostatic products. The company's antimicrobial technology is
a revolutionary alternative to conventional sanitizers, disinfectants, bleaches,
biocides or preservatives primarily because it kills bacteria, including HIV, on
contact and can remain active for extended time periods. To date BioShield has
received three US patents and eight EPA registrations, including the first U.S.
germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus
aureus and other microorganisms. The company has developed several alliances in
different industries, such as healthcare, textiles and storm water.

Further information on BioShield and its line of products can be found by
visiting the firm's web site at http://www.bioshield.com , or by calling
1-770-925-3653, Tim Moses.

Safe Harbor/Forward-looking Statements:

Statements in this news release that are not historical are forward- looking
statements. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in any forward-looking statements, all of which are difficult to
predict and many of which are beyond the control of the company, including areas
such as: developing technologies; dependence on collaborative partners; the
inherent complexity and uncertainty regarding the development of products;
early-stage development of BioShield; the result of research and development
efforts; future capital needs; uncertainty of additional funding; government
regulations; and other factors which are detailed in the company's periodic
reports and registration statements filed with the Securities and Exchange
Commission. BioShield does not undertake to revise or update any forward-looking
statement to reflect events or circumstances that may arise after the date
hereof. BioShield is a trademark of BioShield Technologies, Inc.


MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X86171112

SOURCE BioShield Technologies, Inc.


CONTACT: Tim Moses of BioShield Technologies, Inc., +1-770-925-3653

URL: http://www.bioshield.com
http://www.prnewswire.com

Copyright (C) 2002 PR Newswire. All rights reserved.

-0-


KEYWORD: Georgia
INDUSTRY KEYWORD: CHM
BIO
OTC

(Wall Street)




Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up